SG Americas Securities LLC Boosts Holdings in Smith & Nephew SNATS, Inc. (SNN)

SG Americas Securities LLC grew its holdings in Smith & Nephew SNATS, Inc. (NYSE:SNN) by 183.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 52,100 shares of the medical equipment provider’s stock after acquiring an additional 33,716 shares during the period. SG Americas Securities LLC’s holdings in Smith & Nephew SNATS were worth $1,896,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also bought and sold shares of SNN. Arrowstreet Capital Limited Partnership grew its stake in shares of Smith & Nephew SNATS by 13.8% in the second quarter. Arrowstreet Capital Limited Partnership now owns 2,986,759 shares of the medical equipment provider’s stock worth $104,089,000 after acquiring an additional 362,484 shares in the last quarter. Crossmark Global Holdings Inc. acquired a new position in shares of Smith & Nephew SNATS in the third quarter worth $12,640,000. Goldman Sachs Group Inc. grew its stake in shares of Smith & Nephew SNATS by 95.0% in the second quarter. Goldman Sachs Group Inc. now owns 462,640 shares of the medical equipment provider’s stock worth $16,123,000 after acquiring an additional 225,418 shares in the last quarter. Blue Jay Capital Management LLC purchased a new stake in shares of Smith & Nephew SNATS during the 2nd quarter worth $6,970,000. Finally, Cambiar Investors LLC lifted its position in shares of Smith & Nephew SNATS by 2.8% during the 2nd quarter. Cambiar Investors LLC now owns 5,288,915 shares of the medical equipment provider’s stock worth $184,319,000 after purchasing an additional 145,159 shares during the last quarter. Institutional investors and hedge funds own 6.39% of the company’s stock.

Several equities research analysts have recently issued reports on the stock. Zacks Investment Research cut shares of Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a research report on Wednesday, November 8th. Canaccord Genuity assumed coverage on shares of Smith & Nephew SNATS in a research report on Wednesday, October 11th. They set a “buy” rating and a $42.00 price objective for the company. Finally, BidaskClub raised shares of Smith & Nephew SNATS from a “hold” rating to a “buy” rating in a research report on Tuesday, August 1st. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $42.50.

Smith & Nephew SNATS, Inc. (NYSE SNN) traded down $0.01 during trading on Friday, hitting $35.78. 119,951 shares of the stock traded hands, compared to its average volume of 550,633. Smith & Nephew SNATS, Inc. has a 1-year low of $27.26 and a 1-year high of $40.43. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.18 and a quick ratio of 1.08.

The company also recently disclosed a semiannual dividend, which was paid on Wednesday, November 1st. Stockholders of record on Friday, October 6th were given a dividend of $0.246 per share. The ex-dividend date of this dividend was Thursday, October 5th. This represents a dividend yield of 1.37%.

ILLEGAL ACTIVITY WARNING: “SG Americas Securities LLC Boosts Holdings in Smith & Nephew SNATS, Inc. (SNN)” was originally posted by Transcript Daily and is owned by of Transcript Daily. If you are viewing this story on another site, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this story can be read at https://transcriptdaily.com/2017/11/26/sg-americas-securities-llc-boosts-holdings-in-smith-nephew-snats-inc-snn.html.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew SNATS, Inc. (NYSE:SNN).

Institutional Ownership by Quarter for Smith & Nephew SNATS (NYSE:SNN)

Receive News & Ratings for Smith & Nephew SNATS Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew SNATS Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply